Lunelle(TM) monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): Effects of body weight and injection sites on pharmacokinetics

Contraception

Volumn 60, Issue 4, 1999, Pages 201-208

  Rahimy, Mohamad H ^a   Cromie, Matthew A ^a   Hopkins, Nancy K ^a   Tong, Donald M ^a  

^a PFIZER INC   (United States)

Author keywords

Body weight; Estradiol cypionate; Injection site; Lune(TM); Lunella(TM); Lunelle(TM); Medroxyprogesterone acetate; Monthly contraceptive injection; MPA E2C; Pharmacokinetics

Indexed keywords

CONTRACEPTIVE AGENT; ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; ESTRADIOL; ESTRADIOL 17 BETA CYPIONATE; ESTRADIOL 17 BETA-CYPIONATE; ESTROGEN; HORMONE; MEDROXYPROGESTERONE ACETATE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; BODY WEIGHT; CONTRACEPTION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG STRUCTURE; FEMALE; HUMAN; INJECTION SITE; NORMAL HUMAN; OVULATION; ARM; BIOLOGY; BODY WEIGHT--WOMEN; CLINICAL TRIAL; COMPARATIVE STUDY; CONTRACEPTIVE AGENTS, FEMALE--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS, PROGESTIN--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS--PHARMACODYNAMICS; CONTRACEPTIVE METHODS; DEVELOPED COUNTRY; ENDOCRINE SYSTEM; ESTRADIOL--PHARMACODYNAMICS; FAMILY PLANNING; HIP; INJECTABLES; INTRAMUSCULAR DRUG ADMINISTRATION; KINETICS; MEDROXYPROGESTERONE ACETATE--PHARMACODYNAMICS; MULTICENTER STUDY; NORTH AMERICA; NORTHERN AMERICA; PHYSIOLOGY; RESEARCH REPORT; THIGH; UNITED STATES; WESTERN HEMISPHERE;

AMERICAS; BIOLOGY; BODY WEIGHT--WOMEN; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS, PROGESTIN--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS--PHARMACODYNAMICS; CONTRACEPTIVE METHODS; DEVELOPED COUNTRIES; ENDOCRINE SYSTEM; ESTRADIOL--PHARMACODYNAMICS; ESTROGENS; FAMILY PLANNING; HORMONES; INJECTABLES; MEDROXYPROGESTERONE ACETATE--PHARMACODYNAMICS; NORTH AMERICA; NORTHERN AMERICA; PHYSIOLOGY; RESEARCH REPORT; UNITED STATES; WOMEN;

ADULT; ARM; BODY MASS INDEX; BODY WEIGHT; CONTRACEPTIVE AGENTS, FEMALE; ESTRADIOL; FEMALE; HIP; HUMANS; INJECTIONS, INTRAMUSCULAR; KINETICS; MEDROXYPROGESTERONE 17-ACETATE; THIGH;

EID: 0033233145     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(99)00085-2     Document Type: Article

References (15)

1. United Nations Population Fund. Contraceptive requirements and demand for contraceptive commodities in developing countries in the 1990s. February 1991.
2. Harlap S., Kost K., Forrest J.D. Preventing Pregnancy, Protecting Health A New Look at Birth Control Choices in the United States . 1991;The Guttmacher Institute, New York.
3. Newton J.R., d'Arcangues C., Hall P.E. A review of 'once-a-month' combined injectable contraceptives. J Obstet Gynaecol. 14:(suppl 1):1994;S1-S34.
4. Aedo A.R., Landgren B.M., Johannisson E., Diczfalusy E. Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations. Contraception. 31:1985;453-469.
5. Fotherby K., Benagiano G., Toppozada H.K., et al. A preliminary pharmacological trial of the monthly injectable contraceptive Cyclo-Provera. Contraception. 25:1982;261-272.
6. Koetsawang S., Srisupandit S., Kiriwat O., Koetsawangh. The monthly injectable contraceptive two-year clinical trial . Int J Gynaecol Obstet. 16:1978;61-64.
7. Koetsawang S., Shrimanker K., Fotherby K. Blood levels of medroxyprogesterone acetate after multiple injections of Depo-Provera or Cyclo-Provera. Contraception. 20:1979;1-4.
8. Rahimy M.H., Ryan K.K., Hopkins N.K. Multiple-dose pharmacokinetics (PKs) and pharmacodynamics of the injectable monthly contraceptive Cyclo-Provera (abst 2034). PharmSci. (suppl):1998;1S-148.
9. Zhou X.F., Shao Q.X., Han X.J., Weng L.J., Sang G.W. Pharmacokinetics of medroxyprogesterone acetate after single and multiple injection of Cyclofem® in Chinese women. Contraception. 57:1998;405-411.
10. A multicentered pharmacokinetic, pharmacodynamic study of once-a-month injectable contraceptives. I. Different doses of HRP112 and of DepoProvera. Contraception. 36:1987;441-457.
11. 2 in surgically sterile women . Contraception. 60:1999;209-214.
12. Rahimy M.H., Ryan K.K. Lunelle™ monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) assessment of return of ovulation after three monthly injections in surgically sterile women . Contraception. 60:1999;189-200.
13. Gibaldi M., Perrier D. Pharmacokinetics, 2nd ed. 1982;Marcell Dekker, New York.
14. Fotherby K., Koetsawang S. Metabolism of injectable formulations of contraceptive steroids in obese and thin women. Contraception. 26:1982;51-58.
15. Fotherby K. Factors affecting the duration of action of the injectable contraceptive norethisterone enanthate. Contracept Deliv Syst. 2:1981;249-257.